Subthreshold electrical stimulation (SES) has been shown to induce an improvement of angiogenesis in ischemic and nonischemic skeletal muscles, mediated by increased VEGF expression. VEGF plays a key role in physiological and pathological angiogenesis. Cardiomyocytes possess the ability to synthesize and secrete VEGF. Thus, we thought to investigate the effect of SES on VEGF regulation in cultured neonatal rat ventricular myocytes (NRVMs), in the aim to reveal new techniques for therapeutic angiogenesis in ischemic heart disease. Cell cultures of NRVMs were electrically stimulated with field strengths below the myocyte depolarization threshold (0.5 V/cm with 1 ms bipolar impulse duration). Frequencies ranging from 5 Hz up to 25, 50, and 99 Hz were applied over a period of 48 h. The expression of VEGF and its receptor KDR was determined with Western blot and ELISA. To reveal the biological activity of the secreted VEGF amount, cultured human coronary artery endothelial cells (HCAECs) were treated with the cell culture supernatant of NRVMs exposed to SES. A dominant effect of SES was observed at 25 Hz. Within this particular frequency the VEGF protein amount in the cytoplasm as well as in the cell culture supernatant increased significantly. In parallel, the protein expression of the KDR receptor decreased in a significant manner. Moreover, cell culture supernatant of NRVMs exposed to SES augmented the growth of HCAECs. Cardiomyocytes respond to SES with an increase in biologically active VEGF expression that promotes cell proliferation of HCAECs. This mechanism may provide new approaches to develop therapeutic angiogenesis in the ischemic heart.
INTRODUCTION
Ischemic heart disease (IHD) due to coronary artery disease (CAD) remains the leading cause of death in the Western world (6). Revascularization of existing arteries and the formation of new collateral vessels may be a promising strategic aim in order to improve the function of organs suffering from hypoxia. Vascular endothelial growth factor (VEGF) plays a pivotal role in angiogenesis and neovascularization. There is accumulating evidence that VEGF is expressed in the heart and that its expression
MATERIALS AND METHODS

Cell Cultures of Neonatal Rat Ventricular Myocytes (NRVMs)
All animal experiments were approved by the local and state Ethics in Animal Research Committee (University Hospital RWTH Aachen, Germany, TV-No. 10596 A). NRVMs were isolated and cultured as described previously by Simpson et al. with little modifications according to the protocol by Zobel et al. (14, 16) . After cervical dislocation, hearts were obtained from 1-to 3-day old Sprague-Dawley rats with no consideration to the gender (Charles River, Sulzfeld, Germany) and digested with collagenase II (1.0 mg/ml, 280 U/mg, C2-22; Biochrom, Berlin, Germany), trypsin (0.5 mg/ml, trypsin 1:250, L-11-002; PPA, Colbe, Germany), and 1% penicillin-streptomycin (P-4458; Sigma-Aldrich, Steinheim, Germany). Myocytes were purified from fibroblasts by passage through a Percoll gradient (P-1644; Sigma-Aldrich). Myocytes were plated onto six-well dishes (140685; Nunc, Schwerte, Germany) at a density of 3 × 10 5 cells per well. Cells were grown in DMEM/Ham's F-12 + l-glutamine (FG-4815; Biochrom) supplemented with 10% horse serum (B15-021; PPA) and 5% fetal bovine serum (A-15-101; PPA). After 24 h, the serum medium was removed, and the cells were washed and maintained in serum-free DMEM/Ham's F-12 + l-glutamine.
Human coronary artery endothelial cells (HCAECs) were grown in endothelial cell growth medium (C-22020; PromoCell GmbH, Heidelberg, Germany) until starting the experiments with NRVM cell-conditioned medium. The tissue used by PromoCell for the isolation of human cell cultures is derived from donors who have signed an informed consent form (this being done by the donor himself, an authorized agent, or a legal agent), which outlines in detail the purpose of the donation and the procedure for processing the tissue.
Application of Subthreshold Electrical Simulation (SES)
Three days after cell isolation, serum-containing medium was changed to serum-free medium, and thereafter NRVMs were stimulated for 48 h with low-voltage, highfrequency bipolar electrical field stimulation (HFES) using the C-PaceEP external pacing system (IonOptix, Wageningen, The Netherlands). The stimulus strength (0.5 V/cm, impulse duration 1 ms) was chosen to yield an electrical field that was well below the threshold that elicited contraction of the cultured myocytes. The lowest capture threshold in the different preparations was 1.0 V/ cm. Lack of contraction of the myocytes was checked every 12 h during the experiment by microscopic inspection of the cultures. The frequencies chosen were 5 Hz, 25 Hz, 50 Hz, and 99 Hz. Cell cultures without HFES served as controls.
ELISA
For VEGF ELISA, each well was normalized to 300,000 cells, and SES steps from 5 Hz up to 25, 50, and 99 Hz were analyzed. The conditioned media was collected at 0, 24, and 48 h after exposure to SES, and protein in the cell culture supernatant was concentrated by using the vivaspin columns from Sartorius (Göttingen, Germany). Samples were assayed by a VEGF ELISA kit from R&D Systems (Minneapolis, MN, USA) with normalized protein amounts according to the manufacturer's instructions. Protein amount was quantified by using the NanoDrop 1000 from Thermo Scientific (Wilmington, DE, USA).
Western Blot
Western blots (WB) to assess VEGF and KDR proteins were performed with normalized protein amounts. For WB, cells were homogenized in lysis buffer containing 20 mM Tris-HCl (pH 8.0; #9090.2; Carl-Roth, Karlsruhe, Germany), 1% nonident P-40 (#74.385; Merck, Darmstadt, Germany), and 10% glycerol (#50405-1; Biomol, Hamburg, Germany). Cell lysates were cleared by centrifugation at 17,000 × g for 20 min. Extracts (100 µg) were subjected to electrophoretic separation through a 10% SDS-polyacrylamide gel (SDS #51430-2, Biomol/ polyacrylamide gel #3029.1; Carl-Roth) and subsequently transferred to a polyvinylidene difluoride membrane (#RPN303F; GE-Healthcare Life Sciences, Freiburg, Germany). The membrane was blocked overnight with 5% bovine serum albumin (#01400-1; Biomol) in phosphatebuffered saline (#L-1825; Biochrom) containing 0.1% Tween 20 (PBST; #TW0020; Rockland, ME, USA). Primary rabbit anti-GAPDH (1:1,000; #2118; Cell Signaling, Danvers, MA, USA), rabbit anti-VEGF (1:150; 19003-1-AP; Acris Antibodies, Herford, Germany), and rabbit anti-KDR (200 µg/ml, 1:100; sc-315; Santa Cruz, Heidelberg, Germany) were incubated overnight. Blots were washed three times with PBST and incubated with goat anti-rabbit horseradish peroxidase-conjugated antibody (GE Healthcare) for 1 h. Finally, the ECL Advance Western Blotting Detection Kit (GE Healthcare Life Sciences) was used to visualize the bands with the advanced luminescent image analyzer LAS-3000 from Fujifilm (Tokyo, Japan). Relative densitometry analyses of the bands were performed with the Multi-Gauche V3.0 software from Fujifilm.
Antibodies
Cells were fixed in 4% paraformaldehyde (8.187.15; KMF, Lohmar, Germany), permeabilized with Triton X-100 (50800-1; Biomol), and blocked with 1% BSA (01400-1; Biomol). Cells were incubated with the primary antibody, (1:150) rabbit anti-VEGF (200 µg/ml, 1:150; sc-507; Santa Cruz) mouse anti-Trop T-C (200 µg/ ml; sc-20025; Santa Cruz) overnight at 4°C and then with a goat anti-rabbit (1:100) and goat anti-mouse (1:100) secondary antibody for 2 h coupled to Alexa Fluor 488 (VEGF) (1 mg/ml; A11008; Invitrogen) or Alexa Fluor 647 (Trop T-C) (1 mg/ml; A20990; Invitrogen). Nuclei were stained with 4¢,6-diamidino-2-phenylindole dihydrochloride (10236276001; Roche Mannheim, Germany). To visualize fluorescence signals, the Axiovert 200M microscope and the AxioVision Rel. 4.5 software from Zeiss (Jena, Germany) were used.
Primary antibodies for Western blot: rabbit anti-GAPDH (1:1,000; #2118; Cell Signaling), rabbit anti-VEGF (1:150; 19003-1-AP; Acris Antibodies), rabbit anti-KDR (200 µg/ml, 1:100; sc-315; Santa Cruz).
RNA Preparation, First-Strand cDNA Synthesis, and Quantitative Real-Time Reverse Transcription-PCR
Total RNA was extracted from NRVMs using the Qiagen RNeasy Mini Kit (Venio, The Netherlands) and following the manufacturer's instructions. A total of 1 µg of RNA were reverse-transcribed using random hexamers from the Fermentas First strand cDNA Synthesis Kit (#K1622; Fermentas GmbH, St. Leon-Rot, Germany).
Quantitative Real-Time Reverse-Transcription-PCR
Real-time PCR was performed in 96-well plates on the Step-One plus Sequence Detection System (ABI) as described previously (9). Data were collected with instrument spectral compensation by Applied Biosystems SDS 1.2.3 software (Applied Biosystems, Foster City, CA, USA).
Primers and Probes for Quantitative Real-Time Reverse-Transcription-PCR
PCR primers and fluorogenic probes for the target gene and the endogenous control were purchased as Assays-On-Demand (Applied Biosystems). The assay numbers for the endogenous control and target genes were as follows: Rn00560865_m1 (b-2 microglobulin), Rn01533872_m1 (Ngfb), Rn00561661_m1 (Nppa). The assay numbers were as follows: Rn01511602_m1 (VEGF), Rn00564986_m1 (KDR), Rn00560865_m1 (b-2 microglobulin),
Investigation of Human Coronary Artery Endothelial Cell (HCAEC) Proliferation
To reveal the proliferation of HCAECs due to an effect of biologically active VEGF secreted by NRVMs exposed to SES, we used a colorimetric Assay kit from PromoCell (WST-8). WST-8 is bioreduced by cellular dehydrogenases to an orange formazan product that is soluble in cell culture medium. The amount of formazan is directly proportional to the number of living cells. Therefore, this method allows sensitive determination of the number of viable cells in cell culture.
HCAECs were incubated for 48 h with NRVMconditioned medium. The frequencies of 25 Hz and 5 Hz were analyzed, due to the fact that the dominant effect of VEGF induction was observed at 25 Hz (compared to 5 Hz and control).
Statistical Analysis
All values are expressed as mean ± SEM. Data were processed using Statistical Package for Social Sciences release 14.0 for Windows (IBM, Somers, NY, USA). The statistical significance of differences was evaluated by the Student's t-test for two groups and one-way ANOVA followed by LSD post hoc test for multiple groups. A value of p < 0.05 was accepted as statistically significant.
RESULTS
SES Augments VEGF Expression and Secretion in Neonatal Rat Ventricular Myocytes (NRVMs)
To analyze the effect of SES on cardiomyocyte VEGF expression, NRVMs in cell culture were stimulated for 48 h at 5 Hz, 25 Hz, 50 Hz, and 99 Hz. VEGF protein amount was measured from cell culture medium at 24 and 48 h of stimulation. HFES elicited an increase in VEGF expression both in the cytoplasm and supernatant. A dominant effect of SES was observed at 25 Hz with a 1.8-fold increase of VEGF protein amount in the cytoplasm (Fig. 1) . In parallel, VEGF in the cell culture supernatant rose significantly with an almost bell-shaped dose-response curve and a maximum at 25 Hz. The effect of HFES on VEGF expression was sustained for at least 48 h at all HFES frequencies (Fig. 2) . Figure 3 shows VEGF immunocytofluorescence images of the VEGF expression in cardiomyocytes, which were exposed to subthreshold high-frequency electrical fields in vitro.
In order to evaluate which was the relative contribution of augmented VEGF gene expression on elevated VEGF protein expression, we analyzed the VEGF mRNA content of cell lysates.
Changes of VEGF mRNA and VEGF Receptor During HFES in NRVMs
HFES led to significant decreases in VEGF mRNA, which was significant for 25, 50, and 99 Hz with a maximum at 25 Hz (Fig. 4 ). Since this might be due to a negative feedback loop in response to the increased VEGF protein levels both in the cytoplasm and in the supernatant, we measured the expression of the membranous VEGF receptor (KDR) both on protein ( Fig. 5 ) and mRNA levels (Fig. 6) . SES significantly decreased the expression of the KDR receptor protein at 25 Hz andthough not significantly-at 50 and 99 Hz. Likewise, the KDR receptor mRNA expression was significantly augmented during SES at 25, 50, and 99 Hz (Fig. 6 ). Of note, the relative suppression of VEGF mRNA expression and KDR protein and gene expression followed the frequency dependency as observed for the induction of VEGF protein with a maximum at 25 Hz.
SES-Induced VEGF Expression Is Biologically Active and Promotes Human Coronary Artery Endothelial Cell Proliferation
To investigate whether the observed VEGF induction by SES is effective in promoting endothelial cell proliferation, HCAECs were incubated with NRVM-conditioned medium (48 h of SES at 5 Hz, 2 5Hz, 50 Hz, and 99 Hz, respectively). We found that medium conditioned by 25 Hz SES augmented the growth of HCAECs, whereas the medium conditioned by 5 Hz SES did not elicit a significant growth response of HCAECs in vitro (Fig. 7) .
DISCUSSION
The principal findings of our study are (a) SES of cultured NRVMs elicits a significant increase in VEGF protein expression, (b) the dominant frequency of VEGF induction by SES was 25 Hz, (c) NRVM VEGF secretion due to SES is biologically active and promotes HCAEC proliferation in vitro.
The most dominant effect of SES on VEGF expression was present at 25 Hz with an almost twofold increase in extracellular VEGF protein levels. A frequency dependency of VEGF expression during in vitro SES was previously described in other cell lines with the optimal electrical frequency varying for different cell types, that is, 50 Hz for skeletal muscle cells and 24 Hz for smooth muscle cells (5). The exact mechanism by which HFES augments cellular protein expression is unclear. In myocardial or cardiac neuronal cells, the functional excitatory effects of electrical stimulation (e.g., muscle cell contraction or neuronal firing) depends on the membrane depolarization, which in turn is determined by its refractory period, with higher frequencies being typically effective in cardiac neuronal cells due to its shorter refractory periods. Trophic effects of SES have also been described in sympathetic or parasympathetic cardiac neuronal cells (reference our group). High-frequency stimulation led to an increased NGF and NT-3 protein and gene expression with subsequent induction of neuronal cell growth and hypertrophy in vitro and in vivo (8). However, as opposed to the present study, this effect was dependent on neuronal cell membrane depolarization, since suprathreshold current was delivered, and the effect was blunted by lidocaine (10). In this study, subthreshold electrical stimuli that were not capable of myocardial depolarization. Thus, different electrical effects than only cell membrane depolarization may be operative.
Most notably, SES seems to represent a ubiquitous mechanism by which cellular expression of growth factors can be enhanced. This is further supported by the observation of a frequency-dependent increase in insulinlike growth factor-2 protein and gene expression in osteosarcoma cells (1). In fact, this effect may not solely be restricted to the induction of growth factors, since an increase in constitutive NO synthase during SES of cardiomyocytes has also been described (5).
Theoretically, SES could increase the stability of VEGF protein. However, Kanno et al. showed that electrical stimulation did not affect the stability of VEGF mRNA. This is evidence that the augmentation of VEGF mRNA by electrical stimulation occurs predominantly at the transcriptional level. In addition, transient electrical stimulation (2 h vs. 24 h) led to almost identical VEGF mRNA levels indicating that the initial mRNA increase elicited by SES was sufficient to induce a sustained augmentation of VEGF protein synthesis. This is further supported by the observation of a later onset of the increase in VEGF protein expression 12 h after initiation of SES with a subsequent maximum at 48 h (4).
In the present study, the VEGF mRNA amount was decreased after 48 h of SES despite an increase in VEGF protein. Since KDR receptor mRNA and protein were decreased, a negative feedback mechanism of increased VEGF protein levels on VEGF mRNA expression via downregulated KDR expression might be operative. In fact, Hang and colleagues have already shown that the VEGF mRNA expression gradually decreases during prolonged electrical stimulation and that VEGF-induced angiogenesis may be under a negative feedback control (3). Thus, if a limited exposure of SES is capable of inducing an increase in VEGF mRNA sufficient to induce a sustained VEGF protein expression, the reflectory downregulation of VEGF mRNA expression may already occur within the 48-h stimulation period, thus yielding overall lower mRNA levels than in the control group.
Of note, a negative feedback loop secondary to SESinduced VEGF upregulation might counteract the beneficial effect of SES on therapeutic angiogenesis. Since, in a potential clinical application scenario, SES may only be applied on a short-term basis (e.g., via an intracardiac wire or catheter), the induction of angiogenesis may still be sufficient for a clinically meaningful effect on revascularization. Such a hypothesis is supported by the present study in which a short-term SES exposure of 48 h led to a VEGF protein increase sufficient to induce a cellular growth in vitro.
There are several compelling studies showing the beneficial effects of chronically applied electrical field stimulation to various cell culture and animal models. A study by Shafy and colleagues demonstrated that chronic electrical stimulation via a cardiac resynchronization therapy device contributes to cell differentiation of autologous cultured myoblasts, injected into the infracted areas in a sheep model of myocardial infarction. The authors could show that this technical approach resulted in an improvement in myocardial function (12). Recently Haneef et al. furthermore demonstrated that electrostimulation of stem cells is a safe and effective approach for cell survival and differentiation into cardiac cells (2). Regarding the role of VEGF, Spadaccio and coworkers revealed in an in vivo model of myocardial infarction that continued electrical stimulation contributes to an improvement in myocardial function paralleled by an increase in angiogenesis through endothelial progenitor cell migration and VEGF production (15). These novel studies encourage the investigation of myocardial tissue engineering to develop new therapeutic tools for ischemic heart disease. Our results are completely in line with these findings. Moreover, in the field of new therapeutic approaches for the treatment of heart diseases, it is likely safer to have the opportunity to perform SES to avoid side effects like arrhythmias.
Study Limitations
We did not investigate the mechanisms by which SESinduced VEGF augmentation affected the decrease in VEGF mRNA (negative feedback loop). Future experiments using KDR receptor antibodies during SES and analysis of the intracellular signaling cascades leading to the downregulation of VEGF mRNA may further elucidate these mechanisms.
In the present study, we used an in vitro model of cultured CM from neonatal rats. The expression pattern of VEGF may vary significantly between neonatal and adult rat cardiomyocytes. In addition, we did not analyze the SES response in hypoxic myocytes, as they may be found in the infarction border zone.
Therapeutical angiogenesis after myocardial infarction remains a promising, but challenging, task for cardiovascular medicine. Its importance stems from the high morbidity and mortality due to sequels of occlusive CAD like arrhythmias and heart failure. Several attempts to induce angiogenesis have been investigated (like stem cells, local administration of recombinant angiogenetic growth factors: fibroblast growth factor, VEGF).
The current proof-of-concept study shows that SES is capable of boosting endogenous VEGF expression in ventricular myocytes, which in turn is able to induce proliferation of endothelial cells, thus potentially inducing angiogenesis. SES may be delivered via stimulating catheters positioned either at the endocardial site of the LV or via stimulating (PCI) wires, which may be introduced into the coronary artery (e.g., after revascularization or even in nonoccluded small vessels not amenable to PCI) or accompanying venous vessels (coronary sinus tributaries). The fact that this approach does not rely on the introduction of cells or proteins in myocardial targets by injection or infusion and stimulation from a single electrode pair may cover a larger area makes this approach potentially attractive for further in vivo studies in animal models of CAD.
CONCLUSIONS
Cardiomyocytes stimulated by low-voltage electrical fields produce potent amounts of the angiogenetic factor VEGF, which has positive proliferation effects on HCAECs in vitro. This is a very potent step forward to the treatment of IHD. Angiogenesis due to SES may be one optional alternative treatment of CAD.
